Acute cholangitis: Diagnosis and management.


Journal

Journal of visceral surgery
ISSN: 1878-7886
Titre abrégé: J Visc Surg
Pays: France
ID NLM: 101532664

Informations de publication

Date de publication:
Dec 2019
Historique:
pubmed: 30 6 2019
medline: 24 6 2020
entrez: 29 6 2019
Statut: ppublish

Résumé

Acute cholangitis is an infection of the bile and biliary tract which in most cases is the consequence of biliary tract obstruction. The two main causes are choledocholithiasis and neoplasia. Clinical diagnosis relies on Charcot's triad (pain, fever, jaundice) but the insufficient sensitivity of the latter led to the introduction in 2007 of a new score validated by the Tokyo Guidelines, which includes biological and radiological data. In case of clinical suspicion, abdominal ultrasound quickly explores the biliary tract, but its diagnostic capacities are poor, especially in case of non-gallstone obstruction, as opposed to magnetic resonance cholangiopancreatography and endoscopic ultrasound, of which the diagnostic capacities are excellent. CT scan is more widely available, with intermediate diagnostic capacities. Bacteriological sampling through blood cultures (positive in 40% of cases) and bile cultures is essential. A wide variety of bacteria are involved, but the main pathogens having been found are Escherichia coli and Klebsiella spp., justifying first-line antimicrobial therapy by a third-generation cephalosporin. Systematic coverage of Enterococcus spp. and anaerobic infections remains debated, and is usually recommended, in case of severity criteria for Enterococcus severity levels, or anaerobic bilio-digestive anastomosis for anaerobes. Presence of a biliary stent is the only identified risk-factor associated with infections by multidrug-resistant pathogens. Along with antimicrobial therapy, endoscopic or radiological biliary drainage is a crucial management component. Despite improved management, mortality in cases of acute cholangitis remains approximately 5%.

Identifiants

pubmed: 31248783
pii: S1878-7886(19)30067-0
doi: 10.1016/j.jviscsurg.2019.05.007
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

515-525

Informations de copyright

Copyright © 2019. Published by Elsevier Masson SAS.

Auteurs

A Sokal (A)

Internal medicine unit, hôpital Beaujon, Assistance-publique des Hôpitaux de Paris, 92110 Clichy, France.

A Sauvanet (A)

Hepatic and pancreatic surgery unit, digestive disease center, hôpital Beaujon, Assistance-publique des Hôpitaux de Paris, 92110 Clichy, France.

B Fantin (B)

Internal medicine unit, hôpital Beaujon, Assistance-publique des Hôpitaux de Paris, 92110 Clichy, France; Inserm, IAME, UMR 1137, université Paris Diderot, 75018 Paris, France.

V de Lastours (V)

Internal medicine unit, hôpital Beaujon, Assistance-publique des Hôpitaux de Paris, 92110 Clichy, France; Inserm, IAME, UMR 1137, université Paris Diderot, 75018 Paris, France. Electronic address: victoire.de-lastours@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH